ScholarIQanswers from OpenAlex

0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment

PaperCitations, authors & open-access status

0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment is a paper indexed in ScholarIQ from OpenAlex.

How many citations does 0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment have?

ScholarIQcitation count

0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment has 0 citations in the OpenAlex counts ScholarIQ stores.

When was 0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment published?

ScholarIQyear

0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment has 2019 year in the ScholarIQ index.

What is the open-access status of 0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment?

ScholarIQoa status

0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment has bronze oa status in the ScholarIQ index.

What is the DOI of 0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment?

ScholarIQdoi

The DOI for 0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment is on the source record.

What is the OpenAlex record for 0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment?

ScholarIQopenalex

The OpenAlex for 0767 Long-term Safety Of Sodium Oxybate In Pediatric Narcolepsy With Cataplexy: Open-label Continuation Post 1-year of Treatment is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial